nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—telencephalic ventricle—malignant glioma	0.0449	0.109	CbGeAlD
Acamprosate—GRIN1—telencephalic ventricle—malignant glioma	0.0283	0.0686	CbGeAlD
Acamprosate—GRIN2B—telencephalic ventricle—malignant glioma	0.027	0.0654	CbGeAlD
Acamprosate—GRM5—brainstem—malignant glioma	0.0121	0.0294	CbGeAlD
Acamprosate—GRM5—telencephalon—malignant glioma	0.0108	0.0261	CbGeAlD
Acamprosate—GRIN2C—brainstem—malignant glioma	0.00925	0.0224	CbGeAlD
Acamprosate—Paranoid reaction—Carmustine—malignant glioma	0.00899	0.0252	CcSEcCtD
Acamprosate—GRIN2D—brainstem—malignant glioma	0.0086	0.0208	CbGeAlD
Acamprosate—GRIN2C—telencephalon—malignant glioma	0.00821	0.0199	CbGeAlD
Acamprosate—GRM5—midbrain—malignant glioma	0.00773	0.0187	CbGeAlD
Acamprosate—GRIN1—brainstem—malignant glioma	0.00766	0.0186	CbGeAlD
Acamprosate—GRIN2D—telencephalon—malignant glioma	0.00763	0.0185	CbGeAlD
Acamprosate—GRM5—spinal cord—malignant glioma	0.00755	0.0183	CbGeAlD
Acamprosate—GRIN2B—brainstem—malignant glioma	0.00731	0.0177	CbGeAlD
Acamprosate—GRIN3A—telencephalon—malignant glioma	0.00717	0.0174	CbGeAlD
Acamprosate—GRIN1—telencephalon—malignant glioma	0.0068	0.0165	CbGeAlD
Acamprosate—GRIN2B—telencephalon—malignant glioma	0.00649	0.0157	CbGeAlD
Acamprosate—GRIN2C—medulla oblongata—malignant glioma	0.00645	0.0156	CbGeAlD
Acamprosate—GRIN2A—brainstem—malignant glioma	0.00639	0.0155	CbGeAlD
Acamprosate—SLC36A1—brainstem—malignant glioma	0.00635	0.0154	CbGeAlD
Acamprosate—GRM5—central nervous system—malignant glioma	0.00612	0.0148	CbGeAlD
Acamprosate—GRIN2D—medulla oblongata—malignant glioma	0.00599	0.0145	CbGeAlD
Acamprosate—GRM5—cerebellum—malignant glioma	0.00598	0.0145	CbGeAlD
Acamprosate—Encephalopathy—Carmustine—malignant glioma	0.00595	0.0167	CcSEcCtD
Acamprosate—GRIN2A—telencephalon—malignant glioma	0.00567	0.0137	CbGeAlD
Acamprosate—SLC36A1—telencephalon—malignant glioma	0.00563	0.0136	CbGeAlD
Acamprosate—Paranoia—Carmustine—malignant glioma	0.00561	0.0157	CcSEcCtD
Acamprosate—GRIN2D—spinal cord—malignant glioma	0.00535	0.0129	CbGeAlD
Acamprosate—Myopathy—Temozolomide—malignant glioma	0.00527	0.0147	CcSEcCtD
Acamprosate—Apathy—Temozolomide—malignant glioma	0.00517	0.0145	CcSEcCtD
Acamprosate—Flat affect—Temozolomide—malignant glioma	0.00513	0.0143	CcSEcCtD
Acamprosate—Menorrhagia—Temozolomide—malignant glioma	0.00499	0.014	CcSEcCtD
Acamprosate—GRIN1—midbrain—malignant glioma	0.00488	0.0118	CbGeAlD
Acamprosate—GRM5—brain—malignant glioma	0.00486	0.0118	CbGeAlD
Acamprosate—Abscess—Carmustine—malignant glioma	0.00483	0.0135	CcSEcCtD
Acamprosate—GRIN1—spinal cord—malignant glioma	0.00476	0.0115	CbGeAlD
Acamprosate—GRIN2C—central nervous system—malignant glioma	0.00466	0.0113	CbGeAlD
Acamprosate—GRIN2C—cerebellum—malignant glioma	0.00456	0.011	CbGeAlD
Acamprosate—GRIN2B—spinal cord—malignant glioma	0.00454	0.011	CbGeAlD
Acamprosate—GRIN2A—medulla oblongata—malignant glioma	0.00445	0.0108	CbGeAlD
Acamprosate—GRIN2D—central nervous system—malignant glioma	0.00434	0.0105	CbGeAlD
Acamprosate—Accidental injury—Carmustine—malignant glioma	0.00432	0.0121	CcSEcCtD
Acamprosate—GRIN2D—cerebellum—malignant glioma	0.00424	0.0103	CbGeAlD
Acamprosate—Thinking abnormal—Carmustine—malignant glioma	0.00418	0.0117	CcSEcCtD
Acamprosate—GRIN3A—central nervous system—malignant glioma	0.00408	0.00988	CbGeAlD
Acamprosate—GRIN2A—midbrain—malignant glioma	0.00407	0.00986	CbGeAlD
Acamprosate—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00406	0.0114	CcSEcCtD
Acamprosate—GRIN2A—spinal cord—malignant glioma	0.00397	0.00962	CbGeAlD
Acamprosate—Neck pain—Carmustine—malignant glioma	0.00387	0.0108	CcSEcCtD
Acamprosate—GRIN1—central nervous system—malignant glioma	0.00386	0.00936	CbGeAlD
Acamprosate—Pulmonary embolism—Carmustine—malignant glioma	0.00382	0.0107	CcSEcCtD
Acamprosate—GRIN1—cerebellum—malignant glioma	0.00378	0.00915	CbGeAlD
Acamprosate—GRIN2C—brain—malignant glioma	0.0037	0.00897	CbGeAlD
Acamprosate—Pulmonary embolism—Temozolomide—malignant glioma	0.00369	0.0103	CcSEcCtD
Acamprosate—Vaginal inflammation—Temozolomide—malignant glioma	0.00369	0.0103	CcSEcCtD
Acamprosate—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00369	0.0103	CcSEcCtD
Acamprosate—Urinary incontinence—Carmustine—malignant glioma	0.00369	0.0103	CcSEcCtD
Acamprosate—GRIN2B—central nervous system—malignant glioma	0.00369	0.00893	CbGeAlD
Acamprosate—GRIN2B—cerebellum—malignant glioma	0.0036	0.00873	CbGeAlD
Acamprosate—GABRG2—telencephalon—malignant glioma	0.00357	0.00865	CbGeAlD
Acamprosate—Urinary incontinence—Temozolomide—malignant glioma	0.00357	0.00998	CcSEcCtD
Acamprosate—GABRA1—brainstem—malignant glioma	0.00355	0.00861	CbGeAlD
Acamprosate—Vaginal infection—Temozolomide—malignant glioma	0.00349	0.00975	CcSEcCtD
Acamprosate—GRIN2D—brain—malignant glioma	0.00344	0.00834	CbGeAlD
Acamprosate—Abnormal vision—Carmustine—malignant glioma	0.00333	0.00932	CcSEcCtD
Acamprosate—Mental disability—Carmustine—malignant glioma	0.00332	0.00928	CcSEcCtD
Acamprosate—GRIN3A—brain—malignant glioma	0.00324	0.00784	CbGeAlD
Acamprosate—GRIN2A—central nervous system—malignant glioma	0.00322	0.00781	CbGeAlD
Acamprosate—Abnormal vision—Temozolomide—malignant glioma	0.00322	0.00901	CcSEcCtD
Acamprosate—Phlebitis—Carmustine—malignant glioma	0.00322	0.00901	CcSEcCtD
Acamprosate—Mental disability—Temozolomide—malignant glioma	0.00321	0.00897	CcSEcCtD
Acamprosate—Thrombophlebitis—Carmustine—malignant glioma	0.00321	0.00897	CcSEcCtD
Acamprosate—SLC36A1—central nervous system—malignant glioma	0.0032	0.00776	CbGeAlD
Acamprosate—Diabetes mellitus—Carmustine—malignant glioma	0.00319	0.00892	CcSEcCtD
Acamprosate—GABRA1—telencephalon—malignant glioma	0.00315	0.00764	CbGeAlD
Acamprosate—GRIN2A—cerebellum—malignant glioma	0.00315	0.00763	CbGeAlD
Acamprosate—SLC36A1—cerebellum—malignant glioma	0.00313	0.00758	CbGeAlD
Acamprosate—Thrombophlebitis—Temozolomide—malignant glioma	0.0031	0.00866	CcSEcCtD
Acamprosate—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00308	0.00862	CcSEcCtD
Acamprosate—GRIN1—brain—malignant glioma	0.00307	0.00743	CbGeAlD
Acamprosate—Gastroenteritis—Temozolomide—malignant glioma	0.00303	0.00846	CcSEcCtD
Acamprosate—Injury—Carmustine—malignant glioma	0.00302	0.00844	CcSEcCtD
Acamprosate—Deafness—Temozolomide—malignant glioma	0.003	0.00838	CcSEcCtD
Acamprosate—Amnesia—Carmustine—malignant glioma	0.00295	0.00826	CcSEcCtD
Acamprosate—GRIN2B—brain—malignant glioma	0.00293	0.00709	CbGeAlD
Acamprosate—Amnesia—Temozolomide—malignant glioma	0.00285	0.00798	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00284	0.00795	CcSEcCtD
Acamprosate—Thirst—Temozolomide—malignant glioma	0.00282	0.00788	CcSEcCtD
Acamprosate—GABRG2—medulla oblongata—malignant glioma	0.00281	0.0068	CbGeAlD
Acamprosate—Hyponatraemia—Carmustine—malignant glioma	0.00279	0.00779	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00277	0.00776	CcSEcCtD
Acamprosate—Diplopia—Carmustine—malignant glioma	0.00277	0.00776	CcSEcCtD
Acamprosate—GABRB3—telencephalon—malignant glioma	0.00274	0.00665	CbGeAlD
Acamprosate—Diplopia—Temozolomide—malignant glioma	0.00268	0.0075	CcSEcCtD
Acamprosate—Face oedema—Carmustine—malignant glioma	0.00268	0.00749	CcSEcCtD
Acamprosate—Face oedema—Temozolomide—malignant glioma	0.00259	0.00724	CcSEcCtD
Acamprosate—GABRG2—midbrain—malignant glioma	0.00257	0.00621	CbGeAlD
Acamprosate—Liver function test abnormal—Carmustine—malignant glioma	0.00256	0.00717	CcSEcCtD
Acamprosate—GRIN2A—brain—malignant glioma	0.00256	0.0062	CbGeAlD
Acamprosate—SLC36A1—brain—malignant glioma	0.00254	0.00616	CbGeAlD
Acamprosate—GABRG2—spinal cord—malignant glioma	0.0025	0.00606	CbGeAlD
Acamprosate—GABRA1—medulla oblongata—malignant glioma	0.00248	0.006	CbGeAlD
Acamprosate—Dry skin—Temozolomide—malignant glioma	0.00246	0.00687	CcSEcCtD
Acamprosate—Breast disorder—Temozolomide—malignant glioma	0.00242	0.00678	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00241	0.00675	CcSEcCtD
Acamprosate—Dysphagia—Carmustine—malignant glioma	0.0024	0.00671	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00237	0.00661	CcSEcCtD
Acamprosate—Abdominal distension—Temozolomide—malignant glioma	0.00233	0.00653	CcSEcCtD
Acamprosate—Dysphagia—Temozolomide—malignant glioma	0.00232	0.00648	CcSEcCtD
Acamprosate—GABRA1—midbrain—malignant glioma	0.00226	0.00549	CbGeAlD
Acamprosate—Bronchitis—Temozolomide—malignant glioma	0.00223	0.00623	CcSEcCtD
Acamprosate—GABRA1—spinal cord—malignant glioma	0.00221	0.00535	CbGeAlD
Acamprosate—Hyperglycaemia—Carmustine—malignant glioma	0.00216	0.00605	CcSEcCtD
Acamprosate—GABRB3—medulla oblongata—malignant glioma	0.00216	0.00522	CbGeAlD
Acamprosate—Pneumonia—Carmustine—malignant glioma	0.00215	0.00602	CcSEcCtD
Acamprosate—Pollakiuria—Temozolomide—malignant glioma	0.00214	0.00599	CcSEcCtD
Acamprosate—Erectile dysfunction—Temozolomide—malignant glioma	0.00213	0.00597	CcSEcCtD
Acamprosate—Depression—Carmustine—malignant glioma	0.00213	0.00596	CcSEcCtD
Acamprosate—Photosensitivity reaction—Temozolomide—malignant glioma	0.00212	0.00592	CcSEcCtD
Acamprosate—Weight increased—Temozolomide—malignant glioma	0.00211	0.0059	CcSEcCtD
Acamprosate—Weight decreased—Temozolomide—malignant glioma	0.0021	0.00586	CcSEcCtD
Acamprosate—Hyperglycaemia—Temozolomide—malignant glioma	0.00209	0.00585	CcSEcCtD
Acamprosate—Stomatitis—Carmustine—malignant glioma	0.00208	0.00583	CcSEcCtD
Acamprosate—Urinary tract infection—Carmustine—malignant glioma	0.00208	0.00581	CcSEcCtD
Acamprosate—Pneumonia—Temozolomide—malignant glioma	0.00208	0.00581	CcSEcCtD
Acamprosate—Depression—Temozolomide—malignant glioma	0.00206	0.00576	CcSEcCtD
Acamprosate—GABRG2—central nervous system—malignant glioma	0.00203	0.00492	CbGeAlD
Acamprosate—Stomatitis—Temozolomide—malignant glioma	0.00201	0.00563	CcSEcCtD
Acamprosate—Urinary tract infection—Temozolomide—malignant glioma	0.00201	0.00562	CcSEcCtD
Acamprosate—GABRG2—cerebellum—malignant glioma	0.00198	0.00481	CbGeAlD
Acamprosate—GABRB3—midbrain—malignant glioma	0.00197	0.00477	CbGeAlD
Acamprosate—Haemoglobin—Carmustine—malignant glioma	0.00193	0.0054	CcSEcCtD
Acamprosate—GABRB3—spinal cord—malignant glioma	0.00192	0.00466	CbGeAlD
Acamprosate—Haemorrhage—Carmustine—malignant glioma	0.00192	0.00537	CcSEcCtD
Acamprosate—Hypoaesthesia—Carmustine—malignant glioma	0.00191	0.00534	CcSEcCtD
Acamprosate—Hallucination—Carmustine—malignant glioma	0.00191	0.00534	CcSEcCtD
Acamprosate—Oedema peripheral—Carmustine—malignant glioma	0.00189	0.00529	CcSEcCtD
Acamprosate—Haemoglobin—Temozolomide—malignant glioma	0.00186	0.00521	CcSEcCtD
Acamprosate—Haemorrhage—Temozolomide—malignant glioma	0.00186	0.00519	CcSEcCtD
Acamprosate—Hepatitis—Temozolomide—malignant glioma	0.00186	0.00519	CcSEcCtD
Acamprosate—Visual impairment—Carmustine—malignant glioma	0.00185	0.00517	CcSEcCtD
Acamprosate—Hypoaesthesia—Temozolomide—malignant glioma	0.00185	0.00516	CcSEcCtD
Acamprosate—Hallucination—Temozolomide—malignant glioma	0.00185	0.00516	CcSEcCtD
Acamprosate—Pharyngitis—Temozolomide—malignant glioma	0.00184	0.00515	CcSEcCtD
Acamprosate—Oedema peripheral—Temozolomide—malignant glioma	0.00183	0.00511	CcSEcCtD
Acamprosate—GABRA1—central nervous system—malignant glioma	0.00179	0.00434	CbGeAlD
Acamprosate—Visual impairment—Temozolomide—malignant glioma	0.00179	0.005	CcSEcCtD
Acamprosate—GABRA1—cerebellum—malignant glioma	0.00175	0.00424	CbGeAlD
Acamprosate—Tinnitus—Temozolomide—malignant glioma	0.00173	0.00484	CcSEcCtD
Acamprosate—Alopecia—Carmustine—malignant glioma	0.0017	0.00474	CcSEcCtD
Acamprosate—Mental disorder—Carmustine—malignant glioma	0.00168	0.0047	CcSEcCtD
Acamprosate—Immune system disorder—Temozolomide—malignant glioma	0.00168	0.00469	CcSEcCtD
Acamprosate—Malnutrition—Carmustine—malignant glioma	0.00167	0.00467	CcSEcCtD
Acamprosate—Chills—Temozolomide—malignant glioma	0.00166	0.00466	CcSEcCtD
Acamprosate—Alopecia—Temozolomide—malignant glioma	0.00164	0.00458	CcSEcCtD
Acamprosate—Mental disorder—Temozolomide—malignant glioma	0.00163	0.00455	CcSEcCtD
Acamprosate—Back pain—Carmustine—malignant glioma	0.00162	0.00452	CcSEcCtD
Acamprosate—Malnutrition—Temozolomide—malignant glioma	0.00161	0.00452	CcSEcCtD
Acamprosate—GABRG2—brain—malignant glioma	0.00161	0.0039	CbGeAlD
Acamprosate—Dysgeusia—Temozolomide—malignant glioma	0.00158	0.00442	CcSEcCtD
Acamprosate—Tremor—Carmustine—malignant glioma	0.00157	0.00438	CcSEcCtD
Acamprosate—Back pain—Temozolomide—malignant glioma	0.00156	0.00437	CcSEcCtD
Acamprosate—GABRB3—central nervous system—malignant glioma	0.00156	0.00378	CbGeAlD
Acamprosate—Anaemia—Carmustine—malignant glioma	0.00154	0.00432	CcSEcCtD
Acamprosate—Agitation—Carmustine—malignant glioma	0.00154	0.0043	CcSEcCtD
Acamprosate—GABRB3—cerebellum—malignant glioma	0.00152	0.00369	CbGeAlD
Acamprosate—Tremor—Temozolomide—malignant glioma	0.00151	0.00423	CcSEcCtD
Acamprosate—Ill-defined disorder—Temozolomide—malignant glioma	0.0015	0.00419	CcSEcCtD
Acamprosate—Leukopenia—Carmustine—malignant glioma	0.0015	0.00418	CcSEcCtD
Acamprosate—Anaemia—Temozolomide—malignant glioma	0.00149	0.00417	CcSEcCtD
Acamprosate—Agitation—Temozolomide—malignant glioma	0.00148	0.00415	CcSEcCtD
Acamprosate—Angioedema—Temozolomide—malignant glioma	0.00148	0.00413	CcSEcCtD
Acamprosate—Malaise—Temozolomide—malignant glioma	0.00146	0.00407	CcSEcCtD
Acamprosate—Vertigo—Temozolomide—malignant glioma	0.00145	0.00406	CcSEcCtD
Acamprosate—Convulsion—Carmustine—malignant glioma	0.00145	0.00405	CcSEcCtD
Acamprosate—Leukopenia—Temozolomide—malignant glioma	0.00145	0.00404	CcSEcCtD
Acamprosate—Hypertension—Carmustine—malignant glioma	0.00144	0.00404	CcSEcCtD
Acamprosate—Palpitations—Temozolomide—malignant glioma	0.00143	0.00399	CcSEcCtD
Acamprosate—GABRA1—brain—malignant glioma	0.00142	0.00345	CbGeAlD
Acamprosate—Chest pain—Carmustine—malignant glioma	0.00142	0.00398	CcSEcCtD
Acamprosate—Myalgia—Carmustine—malignant glioma	0.00142	0.00398	CcSEcCtD
Acamprosate—Anxiety—Carmustine—malignant glioma	0.00142	0.00397	CcSEcCtD
Acamprosate—Cough—Temozolomide—malignant glioma	0.00141	0.00394	CcSEcCtD
Acamprosate—Convulsion—Temozolomide—malignant glioma	0.0014	0.00391	CcSEcCtD
Acamprosate—Hypertension—Temozolomide—malignant glioma	0.00139	0.0039	CcSEcCtD
Acamprosate—Confusional state—Carmustine—malignant glioma	0.00138	0.00385	CcSEcCtD
Acamprosate—Myalgia—Temozolomide—malignant glioma	0.00137	0.00385	CcSEcCtD
Acamprosate—Arthralgia—Temozolomide—malignant glioma	0.00137	0.00385	CcSEcCtD
Acamprosate—Anxiety—Temozolomide—malignant glioma	0.00137	0.00383	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00137	0.00382	CcSEcCtD
Acamprosate—Discomfort—Temozolomide—malignant glioma	0.00136	0.0038	CcSEcCtD
Acamprosate—Infection—Carmustine—malignant glioma	0.00135	0.00379	CcSEcCtD
Acamprosate—Dry mouth—Temozolomide—malignant glioma	0.00134	0.00376	CcSEcCtD
Acamprosate—Thrombocytopenia—Carmustine—malignant glioma	0.00134	0.00373	CcSEcCtD
Acamprosate—Tachycardia—Carmustine—malignant glioma	0.00133	0.00372	CcSEcCtD
Acamprosate—Confusional state—Temozolomide—malignant glioma	0.00133	0.00372	CcSEcCtD
Acamprosate—Anaphylactic shock—Temozolomide—malignant glioma	0.00132	0.00369	CcSEcCtD
Acamprosate—Infection—Temozolomide—malignant glioma	0.00131	0.00366	CcSEcCtD
Acamprosate—Anorexia—Carmustine—malignant glioma	0.0013	0.00364	CcSEcCtD
Acamprosate—Thrombocytopenia—Temozolomide—malignant glioma	0.00129	0.00361	CcSEcCtD
Acamprosate—Skin disorder—Temozolomide—malignant glioma	0.00128	0.00358	CcSEcCtD
Acamprosate—Hypotension—Carmustine—malignant glioma	0.00127	0.00356	CcSEcCtD
Acamprosate—Hyperhidrosis—Temozolomide—malignant glioma	0.00127	0.00356	CcSEcCtD
Acamprosate—Anorexia—Temozolomide—malignant glioma	0.00126	0.00351	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00124	0.00348	CcSEcCtD
Acamprosate—GABRB3—brain—malignant glioma	0.00124	0.003	CbGeAlD
Acamprosate—Insomnia—Carmustine—malignant glioma	0.00123	0.00345	CcSEcCtD
Acamprosate—Paraesthesia—Carmustine—malignant glioma	0.00122	0.00343	CcSEcCtD
Acamprosate—Dyspnoea—Carmustine—malignant glioma	0.00122	0.0034	CcSEcCtD
Acamprosate—Somnolence—Carmustine—malignant glioma	0.00121	0.00339	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0012	0.00336	CcSEcCtD
Acamprosate—Insomnia—Temozolomide—malignant glioma	0.00119	0.00333	CcSEcCtD
Acamprosate—Decreased appetite—Carmustine—malignant glioma	0.00119	0.00332	CcSEcCtD
Acamprosate—Paraesthesia—Temozolomide—malignant glioma	0.00118	0.00331	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00118	0.00329	CcSEcCtD
Acamprosate—Dyspnoea—Temozolomide—malignant glioma	0.00118	0.00329	CcSEcCtD
Acamprosate—Somnolence—Temozolomide—malignant glioma	0.00117	0.00328	CcSEcCtD
Acamprosate—Pain—Carmustine—malignant glioma	0.00117	0.00326	CcSEcCtD
Acamprosate—Constipation—Carmustine—malignant glioma	0.00117	0.00326	CcSEcCtD
Acamprosate—Dyspepsia—Temozolomide—malignant glioma	0.00116	0.00324	CcSEcCtD
Acamprosate—Decreased appetite—Temozolomide—malignant glioma	0.00115	0.0032	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00114	0.00318	CcSEcCtD
Acamprosate—Constipation—Temozolomide—malignant glioma	0.00113	0.00315	CcSEcCtD
Acamprosate—Pain—Temozolomide—malignant glioma	0.00113	0.00315	CcSEcCtD
Acamprosate—Feeling abnormal—Carmustine—malignant glioma	0.00112	0.00314	CcSEcCtD
Acamprosate—Gastrointestinal pain—Carmustine—malignant glioma	0.00112	0.00312	CcSEcCtD
Acamprosate—Feeling abnormal—Temozolomide—malignant glioma	0.00109	0.00304	CcSEcCtD
Acamprosate—Body temperature increased—Carmustine—malignant glioma	0.00108	0.00302	CcSEcCtD
Acamprosate—Abdominal pain—Carmustine—malignant glioma	0.00108	0.00302	CcSEcCtD
Acamprosate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00108	0.00301	CcSEcCtD
Acamprosate—Urticaria—Temozolomide—malignant glioma	0.00105	0.00293	CcSEcCtD
Acamprosate—Abdominal pain—Temozolomide—malignant glioma	0.00104	0.00291	CcSEcCtD
Acamprosate—Body temperature increased—Temozolomide—malignant glioma	0.00104	0.00291	CcSEcCtD
Acamprosate—Hypersensitivity—Carmustine—malignant glioma	0.001	0.00281	CcSEcCtD
Acamprosate—Asthenia—Carmustine—malignant glioma	0.000979	0.00274	CcSEcCtD
Acamprosate—Hypersensitivity—Temozolomide—malignant glioma	0.000971	0.00272	CcSEcCtD
Acamprosate—Asthenia—Temozolomide—malignant glioma	0.000946	0.00264	CcSEcCtD
Acamprosate—Diarrhoea—Carmustine—malignant glioma	0.000933	0.00261	CcSEcCtD
Acamprosate—Pruritus—Temozolomide—malignant glioma	0.000932	0.00261	CcSEcCtD
Acamprosate—Dizziness—Carmustine—malignant glioma	0.000902	0.00252	CcSEcCtD
Acamprosate—Diarrhoea—Temozolomide—malignant glioma	0.000902	0.00252	CcSEcCtD
Acamprosate—Dizziness—Temozolomide—malignant glioma	0.000872	0.00244	CcSEcCtD
Acamprosate—Vomiting—Carmustine—malignant glioma	0.000867	0.00243	CcSEcCtD
Acamprosate—Rash—Carmustine—malignant glioma	0.00086	0.00241	CcSEcCtD
Acamprosate—Dermatitis—Carmustine—malignant glioma	0.000859	0.0024	CcSEcCtD
Acamprosate—Headache—Carmustine—malignant glioma	0.000854	0.00239	CcSEcCtD
Acamprosate—Vomiting—Temozolomide—malignant glioma	0.000838	0.00234	CcSEcCtD
Acamprosate—Rash—Temozolomide—malignant glioma	0.000831	0.00232	CcSEcCtD
Acamprosate—Dermatitis—Temozolomide—malignant glioma	0.00083	0.00232	CcSEcCtD
Acamprosate—Headache—Temozolomide—malignant glioma	0.000826	0.00231	CcSEcCtD
Acamprosate—Nausea—Carmustine—malignant glioma	0.00081	0.00227	CcSEcCtD
Acamprosate—Nausea—Temozolomide—malignant glioma	0.000783	0.00219	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TP53—malignant glioma	0.000302	0.00131	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000299	0.0013	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PTK2—malignant glioma	0.000298	0.0013	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000297	0.0013	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BCHE—malignant glioma	0.000296	0.00129	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000295	0.00128	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—malignant glioma	0.000294	0.00128	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—malignant glioma	0.000292	0.00127	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MMP3—malignant glioma	0.000292	0.00127	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—malignant glioma	0.000291	0.00127	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000291	0.00127	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BCHE—malignant glioma	0.000291	0.00127	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PTK2—malignant glioma	0.00029	0.00126	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MDM2—malignant glioma	0.000288	0.00125	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—RAF1—malignant glioma	0.000287	0.00125	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000287	0.00125	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000287	0.00125	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000286	0.00125	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000286	0.00124	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—malignant glioma	0.000284	0.00124	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BAD—malignant glioma	0.000282	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAG2—malignant glioma	0.000279	0.00122	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC6A3—malignant glioma	0.000278	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000274	0.00119	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000273	0.00119	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC6A3—malignant glioma	0.000273	0.00119	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—APC—malignant glioma	0.000273	0.00119	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PTPN11—malignant glioma	0.000268	0.00117	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MDM2—malignant glioma	0.000268	0.00117	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—RAF1—malignant glioma	0.000267	0.00116	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—malignant glioma	0.000267	0.00116	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—BRAF—malignant glioma	0.000262	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000262	0.00114	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—malignant glioma	0.000261	0.00114	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000257	0.00112	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BCHE—malignant glioma	0.000254	0.00111	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00025	0.00109	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000249	0.00109	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000249	0.00109	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—FGFR1—malignant glioma	0.000249	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—malignant glioma	0.000249	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—malignant glioma	0.000245	0.00107	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000244	0.00106	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000243	0.00106	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—FGFR1—malignant glioma	0.000243	0.00106	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000239	0.00104	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—malignant glioma	0.000239	0.00104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—H3F3A—malignant glioma	0.000236	0.00103	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KDR—malignant glioma	0.000235	0.00102	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—malignant glioma	0.000235	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR3—malignant glioma	0.000234	0.00102	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000232	0.00101	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MET—malignant glioma	0.00023	0.001	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—BRAF—malignant glioma	0.000229	0.000997	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—malignant glioma	0.000229	0.000996	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—YWHAE—malignant glioma	0.000228	0.000991	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTRK2—malignant glioma	0.000228	0.000991	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FLT1—malignant glioma	0.000227	0.000986	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DUSP6—malignant glioma	0.000226	0.000982	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000225	0.00098	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—malignant glioma	0.000224	0.000977	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MET—malignant glioma	0.000224	0.000974	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—BRAF—malignant glioma	0.000223	0.000972	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAG1—malignant glioma	0.000223	0.00097	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH3—malignant glioma	0.000222	0.000966	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MDM2—malignant glioma	0.00022	0.000958	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00022	0.000957	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—RAF1—malignant glioma	0.000219	0.000954	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—malignant glioma	0.000219	0.000954	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000219	0.000953	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FBXW7—malignant glioma	0.000218	0.00095	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000216	0.000939	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000215	0.000936	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	0.000214	0.000932	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BDKRB2—malignant glioma	0.000214	0.000932	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—malignant glioma	0.000213	0.000927	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTK2—malignant glioma	0.000213	0.000926	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PTPN11—malignant glioma	0.000212	0.000924	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HES1—malignant glioma	0.000209	0.000909	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NCOR1—malignant glioma	0.000208	0.000904	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PTK2—malignant glioma	0.000207	0.000902	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PTPN11—malignant glioma	0.000207	0.000901	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT2—malignant glioma	0.000205	0.000894	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—malignant glioma	0.000204	0.000887	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HES1—malignant glioma	0.000204	0.000887	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NCOR1—malignant glioma	0.000202	0.000882	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PTPN11—malignant glioma	0.0002	0.000872	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH2—malignant glioma	0.000199	0.000866	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000199	0.000865	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—malignant glioma	0.000197	0.000859	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000197	0.000858	CbGpPWpGaD
Acamprosate—GABRB3—Ion channel transport—RAF1—malignant glioma	0.000195	0.000848	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KNG1—malignant glioma	0.000195	0.000848	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000194	0.000843	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	0.000192	0.000837	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MDM2—malignant glioma	0.000192	0.000835	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—malignant glioma	0.000192	0.000834	CbGpPWpGaD
Acamprosate—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000191	0.000833	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—RAF1—malignant glioma	0.000191	0.000832	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000189	0.000821	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000188	0.000818	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MDM2—malignant glioma	0.000187	0.000814	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—malignant glioma	0.000187	0.000813	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT2—malignant glioma	0.000186	0.000812	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—RAF1—malignant glioma	0.000186	0.000811	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTRK1—malignant glioma	0.000186	0.000808	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000183	0.000796	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—malignant glioma	0.000179	0.00078	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGFR1—malignant glioma	0.000178	0.000774	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGFR1—malignant glioma	0.000173	0.000754	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—malignant glioma	0.000172	0.000751	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—malignant glioma	0.000172	0.000749	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000171	0.000745	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN2B—malignant glioma	0.000171	0.000744	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RAF1—malignant glioma	0.00017	0.000738	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000169	0.000737	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000168	0.000732	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ERBB2—malignant glioma	0.000168	0.000731	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—malignant glioma	0.000167	0.000729	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000167	0.000728	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTK2—malignant glioma	0.000166	0.000723	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—RAF1—malignant glioma	0.000165	0.00072	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—malignant glioma	0.000165	0.00072	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000165	0.000719	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000165	0.000717	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—malignant glioma	0.000164	0.000713	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—malignant glioma	0.000164	0.000712	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—malignant glioma	0.000163	0.000711	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HES1—malignant glioma	0.000163	0.00071	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000162	0.000706	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCOR1—malignant glioma	0.000162	0.000706	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000162	0.000704	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000162	0.000704	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000162	0.000703	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RAF1—malignant glioma	0.00016	0.000696	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—malignant glioma	0.00016	0.000695	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—malignant glioma	0.000158	0.000688	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—malignant glioma	0.000158	0.000687	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—malignant glioma	0.000158	0.000687	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000157	0.000684	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—malignant glioma	0.000156	0.00068	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFRA—malignant glioma	0.000155	0.000676	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000155	0.000675	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000155	0.000674	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000154	0.000672	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—malignant glioma	0.000154	0.00067	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—malignant glioma	0.000154	0.000669	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PTPN11—malignant glioma	0.000152	0.00066	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BRAF—malignant glioma	0.000151	0.000658	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—malignant glioma	0.000151	0.000656	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—malignant glioma	0.00015	0.000653	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00015	0.000651	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—malignant glioma	0.000149	0.000648	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BRAF—malignant glioma	0.000148	0.000646	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PTPN11—malignant glioma	0.000148	0.000643	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000147	0.00064	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000147	0.00064	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—malignant glioma	0.000145	0.000632	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—malignant glioma	0.000144	0.000627	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—malignant glioma	0.000143	0.000624	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—malignant glioma	0.000143	0.000622	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000142	0.000617	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000141	0.000615	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—malignant glioma	0.000141	0.000614	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—malignant glioma	0.00014	0.000611	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFB—malignant glioma	0.000139	0.000607	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGFR1—malignant glioma	0.000139	0.000604	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—malignant glioma	0.000138	0.000599	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—malignant glioma	0.000137	0.000595	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—malignant glioma	0.000137	0.000595	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000135	0.000587	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—malignant glioma	0.000133	0.00058	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—malignant glioma	0.000132	0.000576	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000131	0.000572	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—malignant glioma	0.000131	0.000569	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—malignant glioma	0.00013	0.000565	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—malignant glioma	0.00013	0.000564	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—malignant glioma	0.000129	0.000563	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000128	0.000559	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MDM2—malignant glioma	0.000127	0.000551	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—malignant glioma	0.000127	0.000551	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—RAF1—malignant glioma	0.000126	0.000549	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—malignant glioma	0.000126	0.000549	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—malignant glioma	0.000126	0.000548	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—malignant glioma	0.000126	0.000548	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BAD—malignant glioma	0.000124	0.000541	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—malignant glioma	0.000124	0.000541	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—RAF1—malignant glioma	0.000124	0.000539	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—malignant glioma	0.000123	0.000536	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RAF1—malignant glioma	0.000121	0.000527	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—malignant glioma	0.000121	0.000525	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—malignant glioma	0.00012	0.000524	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—malignant glioma	0.00012	0.000524	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—malignant glioma	0.00012	0.000521	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGF—malignant glioma	0.000119	0.000518	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTPN11—malignant glioma	0.000118	0.000515	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAF1—malignant glioma	0.000118	0.000514	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—malignant glioma	0.000117	0.000508	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—malignant glioma	0.000116	0.000506	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—malignant glioma	0.000113	0.000494	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—malignant glioma	0.000113	0.000493	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000113	0.00049	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—malignant glioma	0.00011	0.00048	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—malignant glioma	0.00011	0.000478	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—malignant glioma	0.00011	0.000478	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MDM2—malignant glioma	0.000109	0.000473	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—RAF1—malignant glioma	0.000108	0.000471	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—malignant glioma	0.000107	0.000466	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—malignant glioma	0.000106	0.000461	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—malignant glioma	0.000105	0.000456	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.000104	0.000453	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—malignant glioma	0.000104	0.000451	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—malignant glioma	0.000103	0.000447	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF2—malignant glioma	0.000101	0.000441	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—malignant glioma	0.0001	0.000436	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—malignant glioma	9.52e-05	0.000415	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—malignant glioma	9.48e-05	0.000413	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAF1—malignant glioma	9.45e-05	0.000411	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—malignant glioma	9.35e-05	0.000407	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—malignant glioma	9.23e-05	0.000402	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—malignant glioma	9.22e-05	0.000402	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—malignant glioma	9.13e-05	0.000398	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—malignant glioma	8.99e-05	0.000391	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—malignant glioma	8.9e-05	0.000388	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—malignant glioma	8.87e-05	0.000386	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—malignant glioma	8.56e-05	0.000373	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—malignant glioma	8.49e-05	0.000369	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—malignant glioma	8.47e-05	0.000369	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—malignant glioma	8.3e-05	0.000361	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—malignant glioma	8.09e-05	0.000352	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—malignant glioma	8.02e-05	0.000349	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—malignant glioma	7.97e-05	0.000347	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—malignant glioma	7.9e-05	0.000344	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—malignant glioma	7.84e-05	0.000341	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—malignant glioma	7.78e-05	0.000339	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—malignant glioma	7.71e-05	0.000335	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—malignant glioma	7.64e-05	0.000333	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—malignant glioma	7.2e-05	0.000314	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—malignant glioma	7.13e-05	0.00031	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	6.78e-05	0.000295	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	6.66e-05	0.00029	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—malignant glioma	6.63e-05	0.000288	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—malignant glioma	6.48e-05	0.000282	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—malignant glioma	6.12e-05	0.000267	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—malignant glioma	5.88e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.82e-05	0.000253	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—malignant glioma	5.74e-05	0.00025	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—malignant glioma	5.62e-05	0.000245	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—malignant glioma	5.44e-05	0.000237	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—malignant glioma	4.59e-05	0.0002	CbGpPWpGaD
